Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history shows a new site revision (v3.6.3) replacing the previous revision (v3.6.2). This reflects an underlying platform update rather than changes to study data or content.SummaryDifference0.1%

- Check24 days agoChange DetectedThe site revision tag was updated from v3.6.0 to v3.6.2, reflecting an updated interface version.SummaryDifference0.1%

- Check38 days agoChange DetectedThe study history now shows that the trial is not enrolling participants. A new revision (v3.6.0) was added, replacing the previous revision (v3.5.5).SummaryDifference0.3%

- Check45 days agoChange DetectedThe revision label in the page history updated from v3.5.4 to v3.5.5, signaling a new build of the page history. This change affects only metadata and does not modify the underlying study information.SummaryDifference0.1%

- Check66 days agoChange DetectedThe history shows the page updating its revision from v3.5.3 to v3.5.4, indicating a new version of the page has been published.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry v3.5.3 was added to the study record history, and the previous revision v3.5.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.